Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
about
sameAs
Catheter based intracoronary brachytherapy leads to increased platelet activationClopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery diseaseAcute coronary syndromes: diagnosis and management, part IHPA-1 polymorphism of alphaIIbbeta3 modulates platelet adhesion onto immobilized fibrinogen in an in-vitro flow system.Platelet adhesion onto immobilized fibrinogen under arterial and venous in-vitro flow conditions does not significantly differ between men and women.The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations.Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.52-year-old woman with intractable nausea and vomitingPositive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes.Effects of an aqueous extract of dangguijagyagsan on serum lipid levels and blood flow improvement in ovariectomized rats.Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASOProtease-activated receptors and myocardial infarctionThe selection of antithrombotic agents in the prevention of recurrent ischemic stroke.Angiogenesis: a link to thrombosis in athero-thrombotic disease.Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular EventsCoronary magnetic resonance imaging: visualization of the vessel lumen and the vessel wall and molecular imaging of arteriothrombosis.Obesity: prevalence, theories, medical consequences, management, and research directionsCurrent strategies for ischemic stroke prevention: role of multimodal combination therapies.Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.Impact of genetic variation on perioperative bleeding.Positive affect and psychobiological processes relevant to health.Identification of patients at risk of ischemic events for long-term secondary prevention.Neutrophil to lymphocyte ratio is associated with proximal/middle segment of the LAD lesions in patients with ST segment elevation infarction.Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?PI3K inhibitors in cardiovascular disease.High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass.Platelet signaling-a primer.Triple oral antithrombotic therapy in atrial fibrillation and coronary artery stenting.Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha.High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.Self-rated health status as a risk factor for future vascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease: the SMART study.Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies.Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.Characterization of coagulation factor synthesis in nine human primary cell typesCrystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin.Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.The biology of caring: researching the healing effects of stress response regulation through relational engagement.PKC inhibition markedly enhances Ca2+ signaling and phosphatidylserine exposure downstream of protease-activated receptor-1 but not protease-activated receptor-4 in human platelets.Clinical significance of baseline platelet reactivity in patients with acute coronary syndrome.
P2860
Q28166830-411DB3C5-CB88-49C9-B2B4-A067856E4E1FQ28219643-D87EE211-ABF2-49BE-BEA6-22442B965171Q30490718-CFA0FA0F-60DF-414F-A8E6-61B86C345A36Q33274590-2D143A42-0D9A-4452-B5F1-EB1C5663A167Q33282914-30DF32DD-77A1-44CD-B13B-A44FE915AB10Q33354913-1EFDBED0-2374-4212-85F6-8625B07259FEQ33369310-FF302047-B642-4925-A8FA-0970276A2F37Q33744221-342F48B3-85B1-4AD8-9F82-532645B92272Q33772041-7B1BD7C7-23A5-4AED-BB41-652D59E9B7C4Q34224271-082B1C3F-2E18-48A8-8D1C-4A1E37184793Q34624871-8D8866E2-7BED-4BF1-A632-483B8FC07BC2Q35064542-BF7003E1-03E4-4094-B074-55F03C791CAAQ35065259-CB8E8081-FDCD-4AF0-9B07-2FF2453A087FQ36030398-654E523A-7832-49A9-BA99-E14F4BAB561FQ36078435-CE7A12BF-8D9F-4B8B-9AAC-343E68FE6006Q36245223-9F6D006F-382A-4653-BF72-5CB4487BE02FQ36249348-17DB0537-0662-4073-B44B-4F8B3D9CEFB3Q36970318-1D76FB4E-4D58-4163-8C6A-ABA8217C4DE0Q36973405-156449B4-C7C2-4BB8-99A8-8C34DCA93FE3Q37174998-0F492F04-6C87-48AA-A55C-D77CE0F671DCQ37455535-9362F3C8-A7E3-41E2-B473-C89F2672748CQ37643803-D448768C-423E-41E6-B10D-B0C4969C19C7Q37739806-8F1CECDF-6C76-43E8-AD55-652F0B70F5B1Q37766688-90E2660E-C792-429A-8297-3F00AACC92E4Q37770447-44F6215C-6B33-45B5-8371-B25D291F8A55Q37772192-80458F18-E751-4266-A122-09C99620ED9AQ37946690-2E3E6800-98F6-4506-9F85-5C333E5BA7D0Q37982455-0266D10E-ED84-4300-A744-0A1C8B3DE7A0Q38123126-BFC6C930-71C0-4E27-871C-5C3A2E149F4AQ38349579-2A78DF70-62BE-4699-A931-2A9CA4A2E4ACQ38436472-D57231A5-4A1C-4277-A2E3-2C3FE42014BCQ39662636-FDBEA80F-E20B-4DC0-BF46-34B4D2119B32Q39764180-1DF08074-E64F-4BA1-B24A-6D96E828E558Q39862966-0DFD78F0-DE65-4992-95D3-24677F57E4B2Q41305826-04EFA4C8-A230-4A0F-855E-1E3ED0502280Q42000406-04F983D7-73E7-42A6-B058-9C47EF42951CQ43232040-460BEFCC-D435-4E28-9567-631F3A6A475BQ44150158-8E5CB1ED-BA31-4FB2-B60A-DD04BCE8B505Q44981820-1C0EBD44-DC47-4D25-A97F-EA82B1E49503Q45255393-086E0EAB-3EE6-4B22-8AB5-96FE691358FE
P2860
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@ast
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@en
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@nl
type
label
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@ast
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@en
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@nl
prefLabel
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@ast
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@en
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@nl
P2093
P3181
P1476
Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences
@en
P2093
P304
P3181
P356
10.7326/0003-4819-134-3-200102060-00014
P407
P577
2001-02-06T00:00:00Z